Literature DB >> 26769826

The non-neuronal heart's acetylcholine in health and disease.

B Lewartowski1, U Mackiewicz2.   

Abstract

In this review we describe the history of almost one century lasting investigations which eventually provided evidence convincing that cardiac myocytes possess all elements of the system of synthesis, intracellular transport and release of acetylcholine (ACh) independent of parasympathetic cholinergic innervation. The myocytes synthesis and release of ACh is tightly connected with their contractile activity. Moreover, it is necessary for maintaining the balance of autonomic control of the heart, particularly important in the heart failure. It has an antyhypertrophic activity and protects myocardium against ischemic/reperfusion injury which shows that it is involved in the regulation of the important cellular signaling pathways. These properties of the non-neuronal ACh system of the heart also rise the hope that it might be used for the therapeutic measures.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26769826

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  3 in total

1.  Non-neuronal cardiac acetylcholine system playing indispensable roles in cardiac homeostasis confers resiliency to the heart.

Authors:  Shino Oikawa; Yuko Kai; Asuka Mano; Hisayuki Ohata; Atsushi Kurabayashi; Masayuki Tsuda; Yoshihiko Kakinuma
Journal:  J Physiol Sci       Date:  2021-01-18       Impact factor: 2.781

Review 2.  The Role of M3 Muscarinic Receptor Ligand-Induced Kinase Signaling in Colon Cancer Progression.

Authors:  Mazen Tolaymat; Shannon M Larabee; Shien Hu; Guofeng Xie; Jean-Pierre Raufman
Journal:  Cancers (Basel)       Date:  2019-03-05       Impact factor: 6.639

3.  RGS3L allows for an M2 muscarinic receptor-mediated RhoA-dependent inotropy in cardiomyocytes.

Authors:  Susanne Lutz; Thomas Wieland; Magdolna K Levay; Kurt A Krobert; Andreas Vogt; Atif Ahmad; Andreas Jungmann; Christiane Neuber; Sebastian Pasch; Arne Hansen; Oliver J Müller
Journal:  Basic Res Cardiol       Date:  2022-03-01       Impact factor: 12.416

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.